Young people across the United States who smoke electronic cigarettes are considerably more likely to start smoking traditional cigarettes within a year than their peers who do not smoke e-cigarettes, according to an analysis led by the University of Pittsburgh and Dartmouth.
Post Tagged with: "Norris Cotton Cancer Center"
Gazette Review – A new study coming out of Dartmouth is showing that television food commercials are stimulating the brains of overweight teenagers more than any other group of people.
Investigators from Dartmouth’s Norris Cotton Cancer Center found teens aged 15-17 years old who had ever mixed alcohol with energy drinks were four times more likely to meet the criteria for alcohol use disorder than a teen who has tried alcohol but never mixed it with an energy drink.
A new randomized clinical trial with Dartmouth investigators has noted significant improvement in several measures among those who began palliative care early.
A neuro-oncology research team at Dartmouth’s Norris Cotton Cancer Center, led by the Director Mark A. Israel, MD with first author Gilbert J. Rahme, PhD, recently identified the transcription factor Id4 as a suppressor of tumor cell invasion in glioblastoma.
The National Cancer Institute (NCI) has renewed its Cancer Center Support Grant to Norris Cotton Cancer Center (NCCC) at Dartmouth, continuing NCCC’s designation as a Comprehensive Cancer Center.
Dartmouth researchers have presented a comprehensive review of the role of sex hormones in the female reproductive tract and evidence supporting a “window of vulnerability” to HIV and other sexually transmitted infections (STIs).
Investigators from Dartmouth’s Norris Cotton Cancer Center published new findings about how the complex parts of the blue light known as the Cherenkov Effect can be measured and used in dosimetry to make radiation therapies safer and more effective.
Why do some patients with systemic sclerosis respond to therapy while others do not? The answer may lie in the fine nuances of a patient’s disease; some patients with similar disease symptoms appear to have distinct biological pathways driving their diseases.
Inserting a specific strain of bacteria into the microenvironment of aggressive ovarian cancertransforms the behavior of tumor cells from suppression to immunostimulation, researchers at Norris Cotton Cancer Center and the Geisel School of Medicine at Dartmouth have found.